This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
19 - 21 October, 2026
The Westin Miyako Kyoto

Shoji Ohuchi, Ph.D., MBA
Co-CEO, CSO and CTO at iBody Inc.
Speaker

Profile

  • 2003 Ph.D. in Chemistry, Kyoto University, Japan
  • 2003-2012 Postdoc and Research Associate, IMSUT, The University of Tokyo, Japan
  • 2012-2018 Senior Scientist, Kyoto University, Japan, TU Darmstadt, Germany, and TU Dresden, Germany
  • 2018-2026 CSO, CSO and CTO, followed by Co-CEO, CSO and CTO, iBody Inc, Japan

Agenda Sessions

  • Marriage of single-cell and cell-free technologies for rapid and comprehensive generation of high-performance antibodies

    13:45